Chapter 43: Drugs for Dermatologic Disorders

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine taking a pill, right?

Just a regular pill to lower your blood pressure and then a few weeks later you realize you're suddenly growing thick hair all over your body.

Oh yeah, it's completely wild.

Right.

But that beautiful, bizarre accident is exactly how pharmacologists discovered one of the most famous baldness cures on the market today.

Yeah, and I mean it perfectly captures how totally wild the world of skin medication really is, you know?

Exactly.

Welcome to the Deep Dive, everyone.

If you're listening to this, you're likely a college student staring down the barrel of your very first pharmacology exam and you need a lifeline.

Which is totally fair because pharmacology can definitely feel like trying to drink from a fire hose.

We are thrilled you're here, but you know, it really doesn't have to be overwhelming.

No, not at all.

When you understand the underlying biological logic, when you actually connect the mechanism of a drug to the physical body, it stops being just this massive list of random names.

Right.

It starts becoming a cohesive story and our mission today is highly specific.

Think of this as your tailored, incredibly efficient study session.

Our source material today is strictly Chapter 43 from Lippincott Illustrated Reviews, Pharmacology Seventh Edition.

The topic is Drugs for Dermatologic Disorders.

And our roadmap is super straightforward.

We're walking through this chapter in its exact sequential order.

We're going to decode all that dense drug info into plain English, ensuring you understand the vital why behind every single mechanism.

Exactly.

We are connecting foundational physiology directly to drug targets and then those therapeutic effects right to the clinical warnings.

But a crucial ground rule for this session, we are not bringing in any outside information.

Right.

If it isn't covered in Chapter 43, we aren't talking about it.

Okay, let's unpack this.

Before we can talk about throwing chemicals at the skin, we kind of have to understand the battlefield itself, right?

Yeah, because the skin isn't just like a wrapper holding your organs in.

It's a highly dynamic complex organ system.

Right.

The text points out its primary functions, protecting us from noxious chemicals, pathogens, UV radiation,

and you know, acting as our thermal regulation system and synthesizing vitamin D.

Yeah.

And to really understand how topical drugs are applied, you need to visualize the structure.

Okay, paint a picture for us.

So picture a cross section of the skin basically in two main layers.

On the very top, you have the epidermis.

Okay.

This is made of several stacked layers of keratinocytes, but the MVP for our purposes is the very outermost layer, the stratum corneum.

The stratum corneum.

Got it.

Think of it like a tightly packed brick wall.

It is your primary physical shield.

And then beneath that brick wall is the dermis.

Exactly.

The text describes it as this connective tissue housing all your specialized equipment basically.

Like what kind of equipment?

You know, your sweat glands, your sebaceous or oil glands, the hair follicles, and the blood vessels.

Okay.

So the chapter notes that dermatologists heavily favor topical agents,

which makes sense, right?

You put the drug exactly where the problem is, which minimizes systemic adverse effects.

You don't want a drug circulating through your whole bloodstream if you just need to fix a dry patch in your elbow.

But here's my pushback.

If the stratum corneum is literally designed by nature to be an impenetrable brick wall against the outside world, how do we get these topical drugs to actually cross it?

Well, that is the fundamental challenge of dermatologic pharmacology.

Bypassing that wall depends entirely on the vehicle you use to deliver the drug.

The vehicle.

Like the cream or whatever.

Exactly.

The text explains that choosing the right formulation, whether it's a cream, an ointment, a gel, a lotion, is based on a few specific variables.

Touch us.

You have to consider the thickness of the stratum corneum in the area you're treating.

Because the skin on your eyelid is vastly different from the skin on your heel.

Oh, that's true.

The heel is way thicker.

Right.

You also factor in the drug's potency.

But perhaps most importantly, you have to decide if the formulation needs to be occlusive.

Occlusive meaning like it seals things in.

Precisely.

So an ointment, which is heavily oil -based, creates this occlusive layer over the skin.

It traps the body's natural moisture underneath it, hydrating that stubborn stratum corneum, which physically swells the cells and allows the active drug to drive deeper into the tissue.

Oh, wow.

So the vehicle delivering the drug is just as crucial as the chemical itself.

It really is.

That makes total sense.

Okay.

We've got the lay of the land.

Now let's zoom in on one specific piece of that equipment in the dermis.

The hair follicle.

Yeah.

What happens when that follicle malfunctions?

Right.

That brings us to the agents used for acne.

So to treat acne effectively, you have to understand the pathology cascade, which the chapter breaks down into four really clear sequential steps.

Walk us through them.

Step one is an increase in androgen production, which typically hits during those lovely teenage years of 12 to 24.

Right.

The hormonal surge.

Exactly.

Then step two, those androgens trigger excessive proliferation of skin cells in the follicle.

These cells basically clump together and form a keratin plug.

A keratin plug.

Scientifically called a microcomidone.

Okay.

So the drain is physically clogged.

It is.

Which leads to step three.

Inside that closed plug follicle, your sebaceous glands are still just pumping out sebum or oil.

Oh no.

Yeah.

So the follicle dilates as it fills up.

Yeah.

And finally, step four.

That trapped pool of oil serves as an absolute feast for a naturally occurring bacteria called

propionibacterium acnes.

E -acnes.

Right.

The bacteria gorge, they proliferate, and trigger a massive inflammatory response from your immune system.

And that resulting inflammation is what you actually see in the mirror as a pustule or a papule.

Exactly.

Okay.

So a four -step cascade means we have four different targets to attack pharmacologically.

Let's look at the arsenal.

First up, antibiotics.

Yep.

We've got topicals like clindamycin and erythromycin.

And then oral ones for moderate to severe cases, right?

Like the macrolides and the tetracyclines, specifically doxycycline and minocycline.

And the mechanism here is actually brilliant.

Yes, oral tetracyclines kill the p -acnes bacteria, but the text emphasizes they also possess significant anti -inflammatory properties.

Oh, interesting.

So it's a two -for -one.

Yeah.

Yeah, they are calming the immune response at the same time.

However, there is a massive clinical warning here, and that is bacterial resistance.

Because if you constantly carpet bomb the skin with antibiotics, the bacteria mutate.

Exactly.

So to outsmart this, the text advises using sabantamicrobial dosing.

Wait, what does that mean?

It means you give a dose of the drug so incredibly low that it provides the anti -inflammatory soothing effect, but it's not actually strong enough to pressure the bacteria to mutate.

That is so clever.

It is.

And you always combine antibiotics with non -antibiotic topicals.

Speaking of non -antibiotic topicals, we have benzoil peroxide.

This is a topical wash or gel that works through bactericidal oxidizing activity.

It literally oxidizes and destroys P.

acnes.

And the beautiful part is the text notes it shows absolutely zero bacterial resistance.

Which is huge.

Yeah.

But a quick real -world warning here.

The classic adverse effect of this oxidizing mechanism is that it will completely bleach your pillowcases and your favorite shirts.

Oh yeah, been there.

Next in the text is azelaic acid.

Ah, yes.

I like to think of this one as the ultimate multitasker.

Totally.

It stops bacterial protein synthesis, it acts as an anti -inflammatory, and it's coming out of the lytic, meaning it helps dissolve that keratin plug.

But the standout feature of azelaic acid, and something you absolutely need to remember for an exam, is its lightening effect on hyperpigmented skin.

Yes.

When a severe pimple finally heals, it often leaves behind a stubborn dark spot known as dyspigmentation.

And because azelaic acid naturally lightens pigment, it is the textbook perfect choice for patients dealing with both inflammatory acne and the dark spots it leaves behind.

Spot on.

We also see Dapsone mentioned, which reduces inflammation by interfering with neutrophil function and dropping the production of tumor necrosis factor alpha, or TNF alpha.

Okay, but let's jump to the most famous heavy -hitting class of acne drugs.

The retinoids.

These are vitamin A derivatives.

Retinoids are fascinating because they go straight to the genetic level.

They interact with specific retinoid receptors to regulate gene expression.

Wait, they change your genes?

Mechanically, they normalize how your keratinocytes differentiate.

So in plain English,

they teach your skin cells how to behave properly, so they stop clumping up and hyperproliferating.

Oh, got it.

So this gives retinoids excellent comedolytic activity to clear that stubborn plug out of the follicle.

Exactly.

The chapter lists topicals for mild to moderate acne,

tretinoin, adapalene, and deseratine.

Okay.

And then there's the oral retinoid isotretinoin, which is reserved strictly for severe, nodular acne.

But altering gene expression and cell proliferation is no joke.

The adverse effects here are intense.

Oh, very intense.

Even the topicals cause heavy erythema peeling and photosensitivity, so patients absolutely must wear sunscreen.

But oral isotretinoin carries the heaviest warnings in this entire section.

Yeah, the safety profile is incredibly strict.

Isotretinoin is absolutely contraindicated in women who are pregnant or intend to become pregnant because of severe taretogenicity.

Meaning it causes devastating birth defects.

Exactly.

It also carries documented risks for psychiatric effects.

Even among the topical creams, tseratine is singled out as highly taretogenic and must be completely avoided during pregnancy.

Good to know.

To round out acne, the text mentions salicylic acid, which is a beta hydroxy exfoliant that chemically penetrates the follicle to clear comedones,

and sulfasetamide sodium, which interferes with bacterial growth and is often paired with sulfur, a keratolytic agent that peels the top layer of skin.

Yep, that covers the acne arsenal.

So we've been talking entirely about a bacteria, P.

acnes, that naturally lives deep in our own oil glands.

But what happens when an outside invader breaches the surface of the skin?

That shifts us from acne to superficial bacterial infections like folliculitis, cellulitis, or impetigo.

The text divides these bacterial targets into gram -positive and gram -negative organisms.

Let's start with the classic over -the -counter trio.

Basutracin, neomycin, and polymixin.

You'll recognize these because they are almost always combined into that standard triple antibiotic ointment you put on a scraped knee.

Yeah, and the text explains the logic of combining them.

Basitracin provides coverage against the gram -positive organisms, while neomycin and polymixin handle the gram -negative ones.

Okay, but the mechanism of polymixin is particularly aggressive, right?

What really is.

It's a cyclic hydrophobic peptide.

What does that mean in plain English?

Well, you can think of a hydrophobic peptide acting almost like a biological detergent.

Bad detergent.

Yeah.

When it comes into contact with the oily lipid -based cell membrane of a bacteria, it physically disrupts and punches holes in that membrane.

Whoa.

Yeah, causing the bacterial cell contents to leak out and the cell to just die.

That is aggressive.

Yeah.

Then there is mupiracin.

If you've ever seen a child with highly contagious honey -colored crusts on their face, you're looking at impetigo caused by external streptococci or staphylococci.

Right.

Mupiracin is a protein synthesis inhibitor that shuts down the bacteria's ability to build proteins.

But its real superpower in this text is its target, right?

Exactly.

It goes after serious gram -positive infections,

specifically methicillin -resistant staphylococcus aureus, or MRSA.

Which is notoriously hard to kill.

Yeah.

It is so effective that hospitals use it intranasally, basically swabbing it inside the nose to completely eradicate MRSA colonization in patients.

Amazing.

The chapter also briefly points to gentamisin for gram -negative bugs and rita -pamulin for gram -positive bugs, both working by inhibiting bacterial protein synthesis.

Yeah.

So we know how to fight bacteria that cause inflammation, but what if a patient's face is bright red, flushed, and inflamed, but there is no primary bacterial infection to It takes us to rosacea.

Right.

Rosacea presents with intense facial erythema, or redness.

To treat that specific symptom, the text introduces two alpha agonists.

Bromonidine, which targets alpha -2 receptors, and oxymethazoline, targeting alpha -1 receptors.

Okay.

So what's the underlying physiology here?

Alpha agonists cause vasoconstriction.

So by applying these drugs topically, you physically shrink the dilated blood vessels in the face, which drastically reduces the visible redness.

Okay, here's where I'm going to push back on the text because I'm genuinely confused.

The chapter lists doxycycline and metronidazole as primary treatments for rosacea.

Right.

Wait, didn't we just establish 10 minutes ago that those are antibacterial drugs?

Why are we throwing antibiotics at a condition that isn't caused by bacteria?

It totally feels like a contradiction, but this is one of the most brilliant pharmacological paradoxes in the chapter.

Oh, really?

Yeah.

In the context of rosacea, we aren't using these drugs to kill bugs at all.

We are exploiting them strictly for their anti -inflammatory and immunosuppressive side effects.

Oh, wow.

This is exactly why doxycycline is administered orally at remarkably low doses for rosacea.

You dial the dose down just enough to get the anti -inflammatory soothing effect without turning it into an active antimicrobial.

That is an amazing distinction to keep in mind, especially for an exam.

Definitely.

The rosacea section finishes with pemacrolimus, which is a topical calcineurin inhibitor that simply decreases inflammation locally.

From there, we transition from the redness of blood vessels to the actual baseline color of the skin itself.

Let's look at the agents for pigmentation disorders.

Okay, so skin color is dictated by melanin, which is produced by melanocytes deep in the basal layer of the epidermis.

And the pathology is pretty straightforward.

Too little melanin is hypopigmentation, and too much is hyperpigmentation.

Exactly.

To treat localized hyperpigmentation, like melasma, which presents as dark brown or gray patches on the face, we use a topical drug called hydroquinone.

Right.

And the mechanism behind hydroquinone is essentially shutting down the melanin factory.

How so?

It works by inhibiting tyrosinase, which is the specific enzyme your cells require to synthesize melanin.

So no enzyme, no pigment.

Simple that.

But there is a heavy warning attached, right?

Yes.

You cannot use hydroquinone in concentrations higher than 4%, and you can't use it for long continuous durations.

Because the text associates it with possible carcinogenicity.

Exactly.

Now, on the other end of the spectrum, if a patient has a hypopigmentation disorder like vitiligo, where patches of skin entirely lose their pigment, we need a drug to add color back.

And that drug is methic saline.

Okay.

The mechanism for methic saline completely threw me.

The text calls it a sorrelin photoactive agent.

And the therapy is called PUVA, sorrelin plus UVA radiation.

Right.

How does a chemical require a literal sunburn to function?

It's an incredible mechanism, really.

Methic saline on its own doesn't do much.

But when it absorbs the specific energy from UV light, the drug physically activates and binds to the DNA inside the skin cells.

Wait, it binds to the DNA.

Yeah, forming what's called a DNA adduct.

By latching onto the DNA, it inhibits faulty DNA replication.

This alters cell proliferation and essentially forces the epithelial cells to differentiate properly and begin repigmenting the skin.

That is wild.

Also, as a quick callback, the text reminds us that tazeratine, that highly teratogenic topical retinoid from the acne section, is used here as well to decrease hyperpigmentation caused by severe photoaging.

Altering DNA replication perfectly sets the stage for the heaviest topic in Chapter 43.

Psoriasis.

Yeah, this is a big one.

We are dealing with a chronic autoimmune disease characterized by massive, out -of -control epidermal cell hyperproliferation.

Right.

If you look at Plaxoriasis, you'll see sharply demarcated, thick, red plaques covered in dry silvery -white scales.

And why is that happening?

The skin cells are replicating at an astonishing speed because they are being constantly stimulated by an abnormal, overactive immune response.

So to fix the skin, we have to quiet the immune system.

We start with apremilast.

This is an oral PDE4 inhibitor that reduces intracellular inflammatory mediators.

Just watch out for drug interactions here.

The text warns to avoid strong CYP450 inducers like carbamazapine or phenytoin because they'll chew the drug up and reduce its efficacy.

Good catch.

Now, when things get severe, we step up to the biologics.

These are incredibly complex, injectable, antibody -based proteins created through recombinant DNA technology.

I like to think of biologics not as broad -spectrum chemical bombs that wipe out the whole immune system but as, like, highly -trained bouncers.

Bouncers.

I like that.

Yeah.

They aren't just tossing everyone out of the club.

They are looking for specific VIP troublemakers, like cytokines, and pulling them out before they can start a riot.

That is a fantastic analogy.

Biologics target specific cytokines that induce T -cell effector function.

For example, some biologics specifically hunt down TNF -alpha.

Which is a major troublemaker.

Huge.

It stimulates keratinocyte proliferation and the release of other inflammatory cytokines.

Drugs in this specific class include etanercept, infliximab, and adalimumab.

Okay.

Are there other bouncers?

Yeah.

Other biologics act as bouncers for IL -12 and IL -23, like eustachinimab, or IL -17A, like succachinimab.

But there is an inherent danger here, right?

Because these bouncers are actively suppressing vital immune responses, patients are left at a much higher risk for dangerous opportunistic infections.

Additionally, because biologics are foreign proteins injected into the human body, the patient's own immune system might recognize them as an enemy.

And attack the drug itself.

Right.

They form anti -drug antibodies against them, which stops the drug from working over time.

Got it.

Now, aside from biologics, the text outlines keratolytic agents like coltar and salicylic acid to physically peel away the sylvie scales.

Yep.

But if we need systemic options, the text highlights methotrexate as the most commonly used systemic therapy for severe psoriasis.

It is an immunosuppressant that reduces DNA synthesis in T lymphocytes.

But there's a crucial monitoring step you cannot forget here.

Right.

Liver function tests are absolutely mandatory due to the risk of severe liver damage.

We also return to the retinoids here, specifically an oral second -generation retinoid called acetretin, used for severe punctular forms of psoriasis.

Okay, here's where it gets really interesting.

Remember those severe pregnancy warnings we discussed for isotretinoin with acne?

Oh, yeah.

Acetretin takes that danger to an entirely different level.

Because it is incredibly teratogenic and because its chemical structure allows it to hide in fat tissues of the body for a very long time, the text explicitly states that women must avoid pregnancy for a staggering three years after stopping the drug.

Three years?

That's unbelievable.

It is.

Furthermore,

absolutely no ethanol can be consumed while on this agent.

None at all.

Finally, the cornerstone of psoriasis therapy for decades,

topical corticosteroids.

They cross the cell membrane, bind intracellular receptors and trigger anti -inflammatory, anti -proliferative and vasoconstrictive effects.

And the chapter ranks these steroids strictly by potency, right?

Yes, starting from low -strength hydrocortisone all the way up to very high -strength clobotocin.

And there is a critical pediatric warning tied to these steroids.

If you apply excessive amounts of potent steroids on a large surface area of a child's body, the drug can absorb through the skin systemically.

Right, which is dangerous.

Very.

It can actually depress the hypothalamic -pituitary -adrenal axis, resulting in systemic growth retardation.

Let me underscore that.

Heavily overusing potent topical steroids can literally stunt a child's growth.

Which is definitely an exam question.

For sure.

The text finishes up psoriasis with vitamin D analogs like calcipotrine and calcitriol, which inhibit keratinocyte proliferation when applied topically.

Okay, so we've covered conditions defined by excessive skin cell growth.

We wrap up the chapter by flipping the script entirely, moving to a condition of diminished growth.

Right, androgenic alopecia, commonly known as male pattern boldness.

The pathology here goes back to hormones.

High levels of a highly potent androgen called DHT or dihydrotestosterone attack the hair follicle.

Causing it to miniaturize and eventually atrophy entirely.

To combat this, the text gives us two drugs.

First, finasteride.

This is an oral drug that specifically inhibits the 5 -alpha reductase enzyme.

Without that key enzyme, normal testosterone cannot convert into the dangerous DHT.

So the hair follicle is protected.

It's exactly.

However, manipulating systemic testosterone conversion comes with significant adverse effects.

Notably decreased libido and erectile dysfunction.

But the strictest warning is actually for pregnant women.

Finasteride cannot be used or even physically handled by pregnant women.

Why physically handled?

Because it can absorb through the skin and there's a severe risk of causing hypospadias, a devastating birth defect of the urethra in a male fetus.

Wow.

Okay, the second drug is minoxidil, which brings us all the way back to our opening story.

Minoxidil was originally a systemic oral drug used to treat high blood pressure.

But patients taking it experienced hypertrichosis, growing hair everywhere as an adverse effect.

So pharmacologists brilliantly reformulated it as a topical foam applied directly to the scalp.

This formulation allows patients to skip the dangerous systemic blood pressure drop, but keep the localized hair growth.

Mechanically, it works by shortening the rest phase of the hair cycle.

But for both finasteride and minoxidil, there is an ultimate catch.

Which is?

You must use them continuously.

The therapeutic benefits only last exactly as long as the drug is present in your system.

If you stop taking the pill or applying the foam, the hormone conversion restarts, the resting phase lengthens, and the hair loss immediately resumes.

Well, that's a bummer.

So what does this all mean?

We have journeyed from the physical protective brick wall of the stratum corneum, deep into the sebaceous glands, and all the way down to the systemic DNA -altering depths of biologics and immunosuppressants.

Yeah.

We've seen how mastering this specific localized physiology, whether that's the four steps of a plug follicle, the overactive melanin factory in the basal layer, or the autoimmune T -cell overdrive driving psoriasis, is the only way to deploy these highly specific pharmacological tools safely and effectively.

Absolutely.

And before we go, I want to leave you with a final thought drawn strictly from the themes we've covered today in Chapter 43.

Consider the incredible irony and the beautiful accidents that define pharmacology and dermatology.

What do you mean?

Notice how many of our most powerful skin treatments are essentially repurposed paradoxes.

We prescribe antibacterial drugs like doxycycline not to kill bacteria, but solely to soothe the redness of rosacea.

Right.

We took a blood pressure medication that caused unwanted hair and engineered it into a billion -dollar topical baldness cure.

We harness incredibly toxic DNA -halting compounds and carefully dose them to normalize out -of -control autoimmune cell growth.

It really is a delicate balance of risks, targets, and vehicles.

The skin might literally be the surface of the body, but the pharmacology we use to treat it runs incredibly deep.

Truly.

Well, that brings us to the end of Chapter 43.

From the Last Minute Lecture Team, we want to give you a warm, encouraging thank you for diving in with us.

We know this material is dense, but you have the biological logic now.

We wish you the absolute best of luck on your pharmacology exams.

You've got this.

Keep studying, and we'll catch you next time.